Mouse Anti-Human IgG4 pFc’ [HP6023] (HRP) (ab99817)
Key features and details
- Mouse Anti-Human IgG4 pFc’ [HP6023] (HRP)
- Conjugation: HRP
- Host species: Mouse
- Isotype: IgG3
- Suitable for: ICC, ELISA, Dot blot, WB, IHC-Fr
Overview
-
Product name
Mouse Anti-Human IgG4 pFc’ [HP6023] (HRP)
See all IgG4 secondary antibodies -
Host species
Mouse -
Target species
Human -
Tested applications
Suitable for: ICC, ELISA, Dot blot, WB, IHC-Frmore details -
Immunogen
Full length protein corresponding to Human IgG4. Human IgG4 myeloma protein
-
Conjugation
HRP
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C. -
Storage buffer
pH: 7.40
Constituents: 50% Glycerol, 50% PBS -
Concentration information loading...
-
Purity
Protein A purified -
Clonality
Monoclonal -
Clone number
HP6023 -
Isotype
IgG3 -
Light chain type
kappa -
Research areas
Associated products
-
Alternative Versions
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab99817 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
ICC |
Use at an assay dependent dilution.
|
|
ELISA |
1/1000 - 1/2000.
|
|
Dot blot |
Use at an assay dependent dilution. for Dot and slot immunoblotting.
|
|
WB |
Use at an assay dependent dilution.
|
|
IHC-Fr |
Use at an assay dependent dilution.
|
Notes |
---|
ICC
Use at an assay dependent dilution. |
ELISA
1/1000 - 1/2000. |
Dot blot
Use at an assay dependent dilution. for Dot and slot immunoblotting. |
WB
Use at an assay dependent dilution. |
IHC-Fr
Use at an assay dependent dilution. |
Images
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (13)
ab99817 has been referenced in 13 publications.
- Gon Y et al. Increased number of T cells and exacerbated inflammatory pathophysiology in a human IgG4 knock-in MRL/lpr mouse model. PLoS One 18:e0279389 (2023). PubMed: 36763580
- Corria-Osorio J et al. Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells. Nat Immunol 24:869-883 (2023). PubMed: 37081150
- Xu H et al. Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives. Microb Cell Fact 20:115 (2021). PubMed: 34107983
- Posadas-Mondragón A et al. Association of Genetic Polymorphisms in TLR3, TLR4, TLR7, and TLR8 with the Clinical Forms of Dengue in Patients from Veracruz, Mexico. Viruses 12:N/A (2020). PubMed: 33138336
- Liu H et al. Disease Severity Linked to Increase in Autoantibody Diversity in IgG4-Related Disease. Arthritis Rheumatol 72:687-693 (2020). PubMed: 31612628